NCT02607358已完成不适用
NATIS: Non-responders to Antiplatelet Treatment in Acute Ischaemic Stroke
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 496
- 试验地点
- 1
- 主要终点
- Responder status
研究概览
简要总结
Determination of frequency of Clopidigrel- and Acetacylicacid-non-responders (HOTPR) in acute ischemic stroke patients.
详细描述
Determination of frequency of Clopidigrel- and Acetacylicacid-non-responders (HOTPR) in acute ischemic stroke patients using the VerifyNow system.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Suspected acute ischemic stroke and loading dose of Clopidogrel or Acetacylicacid
排除标准
- •Previous treatment with platelet inhibitor
- •NOAC or Vitamin K-antagonist treatment
- •Final diagnosis other than Ischemoc stroke or Transitoric ischemic attack
结局指标
主要结局
Responder status
时间窗: immediately
Platelet reactivity with PRU measurement
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
Unknown
Assessment of Antiplatelet resistance like aspirin and clopidogrel in patients with Ischemic stroke using Thromboelastogram Platelet MappingCTRI/2023/07/055555Gleneagles Global Hospital
已完成
4 期
Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent ImplantationAcute Coronary SyndromesPercutaneous Coronary InterventionClopidogrel Low ResponsivenessNCT01094457Shenyang Northern Hospital840
招募中
不适用
Study on the responsiveness of antiplatelet drugs in patients with cerebral infarction.oncardioembolic ischemic strokeJPRN-UMIN000005997Keio University School of Medicine Department of Neurology200
Unknown
2 期
High "on Treatment" Platelet Reactivity in the Intensive Care UnitCritical IllnessNCT02285751Medical University of Vienna200
进行中（未招募）
不适用
Assessing Platelet Inhibitory Response to Clopidogrel – Feasibility, Safety and Cost Analysis of a Tailored Platelet Inhibition Strategy for Elective PCI Patients - Plavix and PrasugrelTo investigate the feasibility, safety and cost of using the platelet assay VerifyNow-P2Y12 to guide optimal P2Y12 platelet inhibition in patients undergoing elective PCI, compared with standard treatment, at a UK tertiary referral cardiology centre.EUCTR2010-018435-18-GBPapworth Hospital NHS Foundation Trust200